Company intelligence / Profile preview
MyungMoon Bio
Hwaseong-si, Gyeonggi-do, South Koreammpharm.co.kr ↗
- Ownership
- Private
- Employees
- ~297
- Development stage
- Other
01
Overview
Myungmoon Pharm is a commercial Korean pharmaceutical company (KRX:017180) with over 250 marketed prescription and OTC medicines and at least two approved small‑molecule products associated with the company in Korea and abroad, while also sponsoring early‑stage clinical trials and pending programs including a TNF-α‑targeted rheumatoid arthritis candidate and a dwarfism program.[1][3]
- Therapeutic areas
- ImmunologyEndocrinologyCardiovascularGastroenterologyOncology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on MyungMoon Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MyungMoon Bio.